According to Article 17 of Regulation (EU) No 596/2014, company Krka, d. d., Novo mesto hereby informs the interested public that it has received the judgement of the Court of Justice of the EU (CJEU) in the perindopril case.

The European Commission decided in 2014 that Krka had allegedly breached Article 101 of the Treaty on the Functioning of the European Union and caused a distortion on the perindopril market in the EU, and imposed on Krka a fine in the amount of EUR 10,000,000. Krka has paid the fine.

Krka filed a claim against the decision at General Court of the EU in 2014 (General Court).

The General Court decided in favour of Krka in December 2018, it found that Krka had not distorted competition and had not breached Article 101 of the Treaty on the Functioning of the European Union.

The Commission filed appeal against the decision of the General Court at the Court of Justice of the EU, consequently Krka formed provisions in the amount of EUR 10,000,000.

On 27 June 2024, the Court of Justice of the EU ruled on the Commission's appeal against the decision of the General Court. The Court of Justice of the EU upheld the Commission's appeal and returned the case to the General Court of the EU for reconsideration.

Krka published the announcements considering the investigation on 26 November 2008, 6 January 2009, 8 July 2009, 3 July 2014, 9 July 2014 and 12 December 2018.

The notice will be published on the Company's website (www.krka.biz) from 1 July 2024 onwards, for a period of at least 5 years.